爱尔兰与英国试验团队因缺乏保留证据而承担的成本估算
该研究旨在估算爱尔兰和英国临床试验中因缺乏保留策略证据而可能产生的成本。研究者选取英国临床试验单位最常用的十种保留策略,假设其最可能的实施方式与成本,构建成本模型并应用于爱尔兰和英国的假设试验场景及三个已发表试验方案。结论认为需要更多评估保留策略的有效性和成本,以避免广泛使用既昂贵又无效的策略。
要点
- 部分保留策略成本极高,如「与常规护理同步安排数据收集」为900–32503.25欧元。
- 低成本策略包括「问卷应答电话提醒」34.58–568.62欧元、「仅站点提醒的参与者访视时间表」79.18–112.23欧元。
- 作者认为部分保留策略的资源投入可能超过已知或想象的保留获益,未知获益时应优先评估。
核心结论
- 需要更多评估试验保留策略的有效性和成本,以避免广泛使用既昂贵又无效的策略。
研究设计与样本
- 选取英国临床试验单位最常用的十种保留策略,假设其最可能的实施方式与成本,构建成本模型并计算成本。
- 成本模型应用于爱尔兰和英国的假设试验场景以及三个已发表试验方案。
主要发现
- 保留策略常描述不清,导致研究者不得不对实施方式乃至策略本身作出假设。
- 基于假设,部分保留策略成本极高:「与常规护理同步安排数据收集」为900–32503.25欧元,「含参与者提醒的站点参与者访视时间表」为304.74–14803.70欧元,「临床试验单位工作人员常规站点访视」与「研究者面对面会议」均为777.67–14753.48欧元。
- 其他策略成本较低:「问卷应答电话提醒」为34.58–568.62欧元,「仅站点提醒的参与者访视时间表」为79.18–112.23欧元,「定向招募站点/全科医生」为30–1620欧元。
临床怎么用
- 原文未据此给出推荐。
局限性
- 保留策略常描述不清,研究者不得不对实施方式以及某些情况下的策略本身作出假设。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Evidence to support the use of many retention strategies in clinical trials is lacking. Despite this, trial teams still need to have some form of retention strategy in their trials to try and avoid high attrition rates. This study aimed to estimate how much this lack of retention evidence might be costing trials in Ireland and the UK. METHODS: We selected the top ten most routinely used retention strategies by Clinical Trial Units in the UK and made assumptions as to how each of these strategies was most likely to be implemented and the costs involved in doing this. We applied our costing model to a hypothetical trial scenario in both Ireland and the UK as well as to three published trial protocols. We developed the costing model and calculated the costs in Microsoft Excel. RESULTS: Retention strategies were often poorly specified, meaning we had to make assumptions about implementation and in some cases about the strategy itself. Based on our assumptions, some retention strategies can be extremely expensive; some of the costliest strategies included "data collection scheduled with routine care" (€900-€32,503.25), "a timeline of participant visits for sites"-with integrated participant reminder (€304.74-€14,803.70), and "routine site visits by CTU staff" and "investigator meetings face to face", both costing (€777.67-€14,753.48). Others such as "telephone reminders for questionnaire response" (€34.58-€568.62), "a timeline of participant visits for sites"-site reminder alone (€79.18-€112.23), and "targeted recruitment of sites/GPs" (€30-€1620) were less costly compared to the other strategies. DISCUSSION: The resources invested in the use of some retention strategies may outweigh known or imagined benefits on retention. Where benefits are currently unknown, evaluation should be a priority. CONCLUSION: More evaluation of the effectiveness and cost of trial retention strategies is needed to avoid widespread use of strategies that are both expensive and ineffective.
引用
- Murphy E, Shiely F, Treweek S, et al. How much is the lack of retention evidence costing trial teams in Ireland and the UK? Trials. 2022. PMID: 35550607. doi:10.1186/s13063-022-06223-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。